These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter. Wang W, Sonders MS, Ukairo OT, Scott H, Kloetzel MK, Surratt CK. Mol Pharmacol; 2003 Aug 15; 64(2):430-9. PubMed ID: 12869648 [Abstract] [Full Text] [Related]
23. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter. Dutta AK, Xu C, Reith ME. J Med Chem; 1998 Aug 13; 41(17):3293-7. PubMed ID: 9703474 [Abstract] [Full Text] [Related]
24. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. Scheffel U, Pögün S, Stathis M, Boja JW, Kuhar MJ. J Pharmacol Exp Ther; 1991 Jun 13; 257(3):954-8. PubMed ID: 2046028 [Abstract] [Full Text] [Related]
25. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex. Boja JW, Carroll FI, Vaughan RA, Kopajtic T, Kuhar MJ. Synapse; 1998 Sep 13; 30(1):9-17. PubMed ID: 9704876 [Abstract] [Full Text] [Related]
26. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. Katz JL, Kopajtic TA, Agoston GE, Newman AH. J Pharmacol Exp Ther; 2004 May 13; 309(2):650-60. PubMed ID: 14755006 [Abstract] [Full Text] [Related]
27. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter. Newman AH, Izenwasser S, Robarge MJ, Kline RH. J Med Chem; 1999 Sep 09; 42(18):3502-9. PubMed ID: 10479283 [Abstract] [Full Text] [Related]
28. Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. Ritz MC, George FR. J Pharmacol Exp Ther; 1993 Mar 09; 264(3):1333-43. PubMed ID: 8450469 [Abstract] [Full Text] [Related]
29. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine. Kolhatkar RB, Ghorai SK, George C, Reith ME, Dutta AK. J Med Chem; 2003 May 22; 46(11):2205-15. PubMed ID: 12747792 [Abstract] [Full Text] [Related]
30. NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profile. Karbon EW, Abreu ME, Erickson RH, Kaiser C, Natalie KJ, Clissold DB, Borosky S, Bailey M, Martin LA, Pontecorvo MJ. J Pharmacol Exp Ther; 1993 May 22; 265(2):866-75. PubMed ID: 8388461 [Abstract] [Full Text] [Related]
31. Dopamine transporter transmembrane domain polar mutants: DeltaG and DeltaDeltaG values implicate regions important for transporter functions. Itokawa M, Lin Z, Cai NS, Wu C, Kitayama S, Wang JB, Uhl GR. Mol Pharmacol; 2000 Jun 22; 57(6):1093-103. PubMed ID: 10825379 [Abstract] [Full Text] [Related]
32. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole. Newman AH, Kulkarni S. Med Res Rev; 2002 Sep 22; 22(5):429-64. PubMed ID: 12210554 [Abstract] [Full Text] [Related]
33. Mercuric chloride and p-chloromercuriphenylsulfonate exert a biphasic effect on the binding of the stimulant [3H]methylphenidate to the dopamine transporter. Schweri MM. Synapse; 1994 Mar 22; 16(3):188-94. PubMed ID: 8197581 [Abstract] [Full Text] [Related]
34. Non-amine dopamine transporter probe [(3)H]tropoxene distributes to dopamine-rich regions of monkey brain. De La Garza R, Meltzer PC, Madras BK. Synapse; 1999 Oct 22; 34(1):20-7. PubMed ID: 10459168 [Abstract] [Full Text] [Related]
35. Structure-activity relationship comparison of (S)-2beta-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes and (R)-2beta-substituted 3beta-(3,4-dichlorophenyl)tropanes at the dopamine transporter. Zou MF, Kopajtic T, Katz JL, Newman AH. J Med Chem; 2003 Jul 03; 46(14):2908-16. PubMed ID: 12825932 [Abstract] [Full Text] [Related]
36. 2beta-Substituted analogues of 4'-iodococaine: synthesis and dopamine transporter binding potencies. Avor KS, Singh S, Seale TW, Pouw B, Basmadjian GP. J Med Chem; 1998 Jun 18; 41(13):2380-9. PubMed ID: 9632371 [Abstract] [Full Text] [Related]
37. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation. Kulkarni SS, Grundt P, Kopajtic T, Katz JL, Newman AH. J Med Chem; 2004 Jun 17; 47(13):3388-98. PubMed ID: 15189035 [Abstract] [Full Text] [Related]
38. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo. Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K, Berger SP. J Pharmacol Exp Ther; 1999 Apr 17; 289(1):110-22. PubMed ID: 10086994 [Abstract] [Full Text] [Related]
39. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter? Li LB, Cui XN, Reith MA. Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr 17; 365(4):303-11. PubMed ID: 11919655 [Abstract] [Full Text] [Related]
40. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons. Hinerth MA, Collins HA, Baniecki M, Hanson RN, Waszczak BL. Synapse; 2000 Dec 01; 38(3):305-12. PubMed ID: 11020233 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]